Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
about
The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx MiceDownregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell linesThe differences between the localizations of MUC1, MUC5AC, MUC6 and osteopontin in quail proventriculus and gizzard may be a reflection of functional differences of stomach parts.Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors.Lower serum folate is associated with development and invasiveness of gastric cancerHepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration.Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cellsIncreased osteopontin and liver stiffness measurement by transient elastography in biliary atresiaGenetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer.Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosisOsteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factorsSmall integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerDiagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progressionInflammatory serum proteins are severely altered in metastatic gastric adenocarcinoma patients from the Chinese populationPost-operative plasma osteopontin predicts distant metastasis in human colorectal cancer.Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.Small integrin-binding proteins as serum markers for prostate cancer detectionPrognostic significance of osteopontin expression in gastric cancer: a meta-analysis.Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.Osteopontin polymorphism increases gastric precancerous intestinal metaplasia susceptibility in Helicobacter pylori infected male.Intracellular Osteopontin Induced by CagA-positive Helicobacter pylori Promotes Beta-catenin Accumulation and Interleukin-8 Secretion in Gastric Epithelial cells.Increased gastric osteopontin expression by Helicobacter pylori Infection can correlate with more severe gastric inflammation and intestinal metaplasia.Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation.Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.Association of osteopontin polymorphism with cancer risk: a meta-analysisEvaluating the efficacy of osteopontin expression as a prognostic marker in oral squamous cell carcinoma in the Indian subpopulation.Abnormal growth factor/cytokine network in gastric cancerOsteopontin as potential biomarker and therapeutic target in gastric and liver cancers.Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.
P2860
Q24628875-AA77A61E-7885-4FE4-B431-6C5B888B3542Q28477541-F810A586-B351-4B24-9928-35EB9305EA1DQ33584162-7D0815CC-6D50-44E0-949D-CD6EE478C3AEQ33841673-4656292F-C9D3-4D3E-9EAA-46CCAA117A66Q34093860-0DB304A0-95B3-479A-97F4-853E2F92AD4AQ34166352-9E770B89-0BB4-451F-B84C-FF71652B2717Q34173692-4F0E997E-CDE5-4D98-8790-1AD41CFA9DE8Q34333173-AF884366-5B34-4CF3-A9A9-06D776DE1335Q34448574-27074768-A3E8-415E-92DE-C5941F57D731Q34482118-F1962400-3589-48BB-825B-722D96554665Q34501850-C9AFE3B6-60A0-465F-B351-E6BAB8C03054Q34639819-87546392-C249-4307-81CF-8350A06BB357Q34655823-B9C28FE1-4762-4251-9248-9BDA6F775600Q35083652-A9F26F66-66B2-4D00-BE4A-9A48BC34C0EDQ35257796-AD120CF1-C859-4481-8B56-B32DC89CF73FQ35464730-C0A02C2B-FEB6-4B40-B66F-75B0B0AACC1CQ35593061-153C89A0-6B29-4331-A96C-1C180C5822E3Q35744040-D3C123AC-79AF-4B0C-A8A3-CBB21E5959D4Q36182332-B40AEC5B-957F-44BC-B60E-9CBDE4792C59Q36344784-990747F0-AFF4-4BFD-9738-BDBA7C4FC2EBQ37056973-FD4D7CF5-ADDE-4749-A203-75E0E6D5E30AQ37121729-67E4F7F3-7F7B-4848-8632-D4256FDB64EDQ37234183-A3B325CF-92D5-4189-9D15-3B6FB6A83931Q37397529-9248B08A-A137-40AC-97C7-371EB2A986EAQ37688419-5C4D2BCB-8DB8-4202-B056-9AEEE22C6B3EQ37745875-F3A1009A-C692-4877-9415-D04C0C67F647Q38078237-D0F5532D-C994-4EFB-84A3-ABB7512DBA60Q38181994-49F473D3-7EC4-4A6B-8575-0EAB1B0A227BQ38661476-DF9A2C60-5854-48FD-BA0B-A731346F13ACQ38904180-EFFEBD98-6933-4265-B27D-C63B93F8B89EQ39541038-47420E8C-110F-4575-A48B-8B6BEFC9526EQ39825484-F111ACC9-551D-412E-8969-8CB668FE4590Q39977787-3DEA9823-F660-4419-9B10-89770FE2C099Q41768065-F57265D8-579B-43D6-9F00-C76A3E0C3048Q41790196-36E8DD1E-0886-4C03-B2E5-AB97017B791FQ41990869-5A18D59A-9084-4026-910F-06174C309017Q43183165-5481DDF4-4133-49CC-8DE6-44B6DD33FE8EQ46196061-861958FA-3EBD-4F88-820A-2C3570D2E6EFQ46874621-A729DD8B-CBEF-4BA9-877F-97AF901AE764Q50060426-445B1171-973B-4539-A7D6-48C7ABE36FA0
P2860
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Elevated plasma osteopontin as ...... opment, invasion and survival.
@ast
Elevated plasma osteopontin as ...... opment, invasion and survival.
@en
type
label
Elevated plasma osteopontin as ...... opment, invasion and survival.
@ast
Elevated plasma osteopontin as ...... opment, invasion and survival.
@en
prefLabel
Elevated plasma osteopontin as ...... opment, invasion and survival.
@ast
Elevated plasma osteopontin as ...... opment, invasion and survival.
@en
P2093
P2860
P356
P1433
P1476
Elevated plasma osteopontin as ...... lopment, invasion and survival
@en
P2093
Cheng-Chung Wu
Chien-Jen Chen
Chun-Ying Wu
Gran-Hum Chen
Jaw-Town Lin
Ming-Shiang Wu
Nai-Hui Chi
Yi-Ju Chen
P2860
P304
P356
10.1136/GUT.2006.109868
P407
P577
2006-12-05T00:00:00Z